Nurture Well Industries Ltd
531889Nurture Well Industries Ltd is cheap for a reason. The P/E sits at the 14th percentile of its own range, and the quarters are still getting worse.
The sharpest disagreement: the P/E sits at the 14th percentile of its own range, but the engine is deteriorating — cheap for a reason until the quarters turn.
The price is in a downtrend (9 weeks in) while the P/E sits at the 14th percentile of its own 3-year range. Underneath, the last four quarters read deteriorating — profit −105.2% year on year, and −8% of the last 3 years' profit arrived as cash. What settles it: whether the quarters turn before the discount closes.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Nurture Well Industries Ltd trades at ₹24.8, in a downtrend and 9 weeks into that stage. That is −16.7% against its own 200-day average. It sits at 25% of a 52-week range of ₹18 to ₹44. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (16 weeks and counting).
Today the stock is in a downtrend — week 9 of stage 4, confirmed. At ₹24.8 it trades −16.7% versus its 200-day average and sits at 25% of its 52-week range (₹18–₹44).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +27,400% while the NIFTY 500 moved +264% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (16 weeks and counting; last ahead the week of 2026-04-30) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Nurture Well Industries Ltd trades at 8.6× P/E, near the bottom of its own range — cheaper only 14% of the time. Its long-run median P/E is 11.5×, measured across 3.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 8.6× is near the bottom of its own range — cheaper only 14% of the time, against a long-run median of 11.5× measured over 3.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +18.5% against a +24.6% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the +44.5%/yr price move, ~+174.0%/yr came from earnings growth and ~−129.5 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Nurture Well Industries Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE slipping at 23.0% — the per-curve reads carry the story. The read is built from 9 quarters across 3 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +33.9% | +489.8% | — | — |
| Profit | +26.9% | +339.7% | — | — |
| EPS | +18.5% | +174.0% | — | — |
| Share price | +24.6% | +44.5% | +177.6% | +79.8% |
4-Factor Sector Score
45.0/100 — rank 10 of 20 in Diversified · 71% evidence confidence
Nurture Well Industries Ltd scores 45.0 out of 100 against the 20 companies it is compared with in Diversified, ranking 10. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 15.8 + 15 + 11.5 + 2.7 = 45. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Nurture Well Industries Ltd reported ₹200 Cr of revenue in the Mar 26 quarter, −16.8% year on year. The last full year, FY26, came in at ₹1,026 Cr. The last four reported quarters add to ₹1,026 Cr. A multi-year compound rate is not shown because the annual history behind it is too short to compute one honestly.
FY26 revenue came in at ₹1,026 Cr (+33.9% on the year). The latest quarter (Mar 26) printed ₹200 Cr, −16.8% year on year.
Acceleration check: trailing-twelve-month revenue grew +34.0% over the last 4 quarters against +76.0%/yr over the last 8 — rolling over; TTM profit +27.0% vs +84.3%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Nurture Well Industries Ltd's operating margin is 0.2% in the Mar 26 quarter, −9.1 percentage points against the same quarter a year ago. Across 6 fiscal years the operating margin has ranged −33.3% to 1,788.2%. The current quarter sits inside that band.
The latest quarter's operating margin is 0.2%, −9.1 pp against the same quarter a year ago. Across 6 fiscal years the operating margin has ranged −33.3%–1,788.2%.
🚨 Why the margin moved: operating margin went −9.1 pp year on year while gross margin went −7.7 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Nurture Well Industries Ltd posted a net loss of ₹1.2 Cr in the Mar 26 quarter. Full-year FY26 profit was ₹85.0 Cr. That loss is 0.6% of the quarter's revenue. The same quarter a year earlier earned ₹22.7 Cr. 1 of the last 12 reported quarters were loss-making.
Mar 26 profit was ₹−1.2 Cr, −105.2% year on year. On the full year, FY26 printed ₹85.0 Cr (+26.9%).
🚨 Why profit moved: revenue contributed −16.8% and the margin −9.1 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +45.3% vs revenue +40.3%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −8% of Nurture Well Industries Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹−22.0 Cr of operating cash against ₹85.0 Cr of profit. After ₹34.0 Cr of capital spending, ₹−56.0 Cr was left as free cash.
FY26: operating cash of ₹−22.0 Cr against reported profit of ₹85.0 Cr, leaving free cash of ₹−56.0 Cr after ₹34.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −8% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −8%: the cash cycle stretched 129 days between FY14 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 129 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Nurture Well Industries Ltd's cash conversion cycle runs 44 days in FY26, up from −85 days in FY14. Capital spending ran ₹112 Cr over the last 3 years. At FY26 sales of ₹1,026 Cr each day of that cycle holds about ₹2.8 Cr, so roughly ₹124 Cr sits inside the business at any moment.
FY26: debtors at 73 days, inventory at 6 days — roughly 0.2 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 44 days, looser than FY14's −85.
The full loop: cash goes out to suppliers and production on day 0; stock waits 6 days to sell; customers pay about 73 days after that; and suppliers themselves are paid at 36 days — netting out to the 44-day cycle.
In money terms: at FY26 sales of ₹1,026 Cr, each day of the cycle holds about ₹2.8 Cr — so the 44-day loop keeps roughly ₹124 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹112 Cr over the last 3 fiscal years against ₹8.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹4.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Nurture Well Industries Ltd earns a ROCE of 23% in FY26. That is up from a trough of −11% in FY14. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 8.3% net margin on 1.82× asset turns.
FY26 ROCE is 23%, recovered from a FY14 trough of −11% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 8.3% net margin × 1.82× asset turns × 1.52× balance-sheet leverage ≈ 23.0% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Nurture Well Industries Ltd carries ₹35.0 Cr of borrowings against ₹370 Cr of equity in FY26, a debt-to-equity of 0.09. Operating profit covers the interest bill 90×. Over 5 years borrowings went from ₹4.9 Cr to ₹35.0 Cr. Capital spending ran ₹112 Cr across the last 3 of those years.
FY26: borrowings of ₹35.0 Cr against equity of ₹370 Cr — a debt-to-equity of 0.09. Operating profit covers the interest bill 90×. Over 5 years borrowings went from ₹4.9 Cr to ₹35.0 Cr while capital spending ran ₹112 Cr in just the last 3 — part of the build-out is riding on borrowed money.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions cut 5.8 points of Nurture Well Industries Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 0.1% of the company. Promoters moved +2.3 points over the same window, to 53.8%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −5.8 points over 8 quarters to 0.1%; Promoters: +2.3 points over 8 quarters to 53.8%; Domestic institutions: +0.1 points over 8 quarters to 0.2%.
🚨 Why the register moved: foreign institutions drove it (−5.8 points), absorbed on the other side by promoters (+2.3 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Nurture Well Industries Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Indiabulls LimitedIBULLSLTD | 61.6/100Mixed-positive evidence67% evidence | LEADER | 18.3/35 Revenue 100% · PAT 100% · OPM change 28 pp 71% evidence | 14.2/25 ROCE 16.2% · OPM 43% 76% evidence | 10.6/20 P/E 13.2× · PEG — 15% evidence | 18.5/20 RS sector 45.4% · RS bench 50.9% · 1Y 82.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 14.2 + 10.6 + 18.5 = 61.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2BCL Industries LtdBCLIND | 61.0/100Mixed-positive evidence83% evidence | FADING | 19.3/35 Revenue -0.8% · PAT 21.1% · OPM change 2 pp 83% evidence | 14.4/25 ROCE 13.9% · OPM 9% 95% evidence | 13.1/20 P/E 9.4× · PEG — 50% evidence | 14.2/20 RS sector -0.4% · RS bench 4.6% · 1Y -17.6%9 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 14.4 + 13.1 + 14.2 = 61 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 33M India Ltd3MINDIA | 59.1/100Mixed-positive evidence90% evidence | TURNING | 17.6/35 Revenue 11.5% · PAT -7.5% · OPM change -1.8 pp 88% evidence | 20.0/25 ROCE 40.5% · OPM 17.2% 100% evidence | 11.7/20 P/E 63.8× · PEG 1.25 100% evidence | 9.8/20 RS sector -3.7% · RS bench 3.4% · 1Y 10.8%2 of 10 weeks ahead 70% evidence |
| Exact sum: 17.6 + 20 + 11.7 + 9.8 = 59.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Grasim Industries LtdGRASIM | 57.6/100Mixed-positive evidence78% evidence | LEADER | 22.9/35 Revenue 18.1% · PAT 32.8% · OPM change 1 pp 83% evidence | 12.8/25 ROCE 8% · OPM 21% 76% evidence | 6.7/20 P/E 42.2× · PEG — 50% evidence | 15.2/20 RS sector 2.2% · RS bench 6.9% · 1Y 14.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 22.9 + 12.8 + 6.7 + 15.2 = 57.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Sobhagya Mercantile Ltd512014 | 56.7/100Mixed-positive evidence71% evidence | ASLEEP | 18.6/35 Revenue 49.3% · PAT 41.8% · OPM change -3.7 pp 83% evidence | 18.5/25 ROCE 23.4% · OPM 10.9% 76% evidence | 9.7/20 P/E 43.3× · PEG — 15% evidence | 9.9/20 RS sector -1% · RS bench 3.7% · 1Y 62.5%6 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 18.5 + 9.7 + 9.9 = 56.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Texmaco Infrastructure & Holdings LtdTEXINFRA | 55.9/100Mixed-positive evidence76% evidence | LEADER | 24.3/35 Revenue 9.9% · PAT 100% · OPM change 78.8 pp 83% evidence | 5.5/25 ROCE 1.4% · OPM -41.9% 95% evidence | 8.7/20 P/E 133× · PEG — 15% evidence | 17.4/20 RS sector 7.9% · RS bench 12.9% · 1Y 15.7%8 of 12 weeks ahead 100% evidence |
| Exact sum: 24.3 + 5.5 + 8.7 + 17.4 = 55.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Kalind Ltd526935 | 55.2/100Mixed-positive evidence67% evidence | BASING | 23.6/35 Revenue — · PAT — · OPM change 21 pp 52% evidence | 18.2/25 ROCE 32% · OPM 63% 76% evidence | 10.6/20 P/E 21.8× · PEG — 50% evidence | 2.8/20 RS sector -84.1% · RS bench 2% · 1Y -44.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 23.6 + 18.2 + 10.6 + 2.8 = 55.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -84.1% and the one-year return is -44.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 8Balmer Lawrie & Company LtdBALMLAWRIE | 53.8/100Mixed-positive evidence82% evidence | ASLEEP | 16.6/35 Revenue 8.9% · PAT 3.8% · OPM change 1 pp 95% evidence | 15.3/25 ROCE 14.6% · OPM 13% 76% evidence | 14.5/20 P/E 10.6× · PEG — 50% evidence | 7.4/20 RS sector -13.8% · RS bench -9.4% · 1Y -20.2%2 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 15.3 + 14.5 + 7.4 = 53.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Tube Investments of India LtdTIINDIA | 46.1/100Mixed-negative evidence96% evidence | ASLEEP | 18.6/35 Revenue 17.4% · PAT 6.1% · OPM change 2 pp 88% evidence | 17.9/25 ROCE 17.1% · OPM 9% 100% evidence | 2.0/20 P/E 80.6× · PEG 9.63 100% evidence | 7.6/20 RS sector -9.1% · RS bench -4.8% · 1Y -4.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 17.9 + 2 + 7.6 = 46.1 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 10Nurture Well Industries Ltdthis page531889 | 45.0/100Mixed-negative evidence71% evidence | ASLEEP | 15.8/35 Revenue 34% · PAT 27% · OPM change -9.1 pp 83% evidence | 15.0/25 ROCE 22.9% · OPM 0.2% 76% evidence | 11.5/20 P/E 8.6× · PEG — 15% evidence | 2.7/20 RS sector -21.8% · RS bench -18.1% · 1Y 23.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.8 + 15 + 11.5 + 2.7 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Bluspring Enterprises LtdBLUSPRING | 43.0/100Thin evidence · provisional57% evidence | TURNING | 18.4/35 Revenue 11.8% · PAT 90.6% · OPM change 0.7 pp 71% evidence | 3.5/25 ROCE 5.1% · OPM 2.2% 95% evidence | 8.9/20 P/E 114× · PEG — 15% evidence | 12.2/20 RS sector — · RS bench 51.5% · 1Y 23.7%10 of 10 weeks ahead 25% evidence |
| Exact sum: 18.4 + 3.5 + 8.9 + 12.2 = 43 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Nava LtdNAVA | 41.7/100Mixed-negative evidence89% evidence | ASLEEP | 9.8/35 Revenue 7.8% · PAT -27.6% · OPM change -5 pp 88% evidence | 14.3/25 ROCE 12.8% · OPM 32% 100% evidence | 13.1/20 P/E 20.5× · PEG 1.16 65% evidence | 4.5/20 RS sector -13.4% · RS bench -9.3% · 1Y -9.6%3 of 12 weeks ahead 100% evidence |
| Exact sum: 9.8 + 14.3 + 13.1 + 4.5 = 41.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 13Swan Corp LtdSWANCORP | 35.8/100Thin evidence · provisional58% evidence | ASLEEP | 15.1/35 Revenue -11.5% · PAT -69% · OPM change -31.6 pp 62% evidence | 6.3/25 ROCE 3.9% · OPM -30% 76% evidence | 10.1/20 P/E 35.2× · PEG — 15% evidence | 4.3/20 RS sector -29.3% · RS bench -22.8% · 1Y -35%0 of 10 weeks ahead 70% evidence |
| Exact sum: 15.1 + 6.3 + 10.1 + 4.3 = 35.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Andrew Yule & Company LtdANDREWYU | 34.7/100Thin evidence · provisional55% evidence | TURNING | 13.2/35 Revenue -4.8% · PAT -80% · OPM change -9 pp 62% evidence | 3.5/25 ROCE -6.3% · OPM -52% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.0/20 RS sector -37% · RS bench 13.8% · 1Y -5.2%10 of 11 weeks ahead 70% evidence |
| Exact sum: 13.2 + 3.5 + 10 + 8 = 34.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Integrated Industries LtdIIL | 64.5/100Thin evidence · provisional50% evidence | 20.6/35 Revenue 60.5% · PAT 94.6% · OPM change 2 pp 53% evidence | 16.7/25 ROCE 30.5% · OPM 11% 57% evidence | 11.0/20 P/E 11.6× · PEG — 15% evidence | 16.2/20 RS sector 51.9% · RS bench 63.7% · 1Y 114.3%11 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 20.6 + 16.7 + 11 + 16.2 = 64.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Arunis Abode LtdARUNIS | 50.8/100Thin evidence · provisional45% evidence | 15.3/35 Revenue 100% · PAT 100% · OPM change -17.7 pp 40% evidence | 9.4/25 ROCE -5.3% · OPM 28.5% 57% evidence | 9.4/20 P/E 62.5× · PEG — 15% evidence | 16.7/20 RS sector 131.3% · RS bench 136.7% · 1Y 395.6%12 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 15.3 + 9.4 + 9.4 + 16.7 = 50.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Piramal Enterprises Ltd(Merged)PEL | 47.8/100Thin evidence · provisional41% evidence | 19.0/35 Revenue 13.3% · PAT 100% · OPM change -0.7 pp 27% evidence | 11.8/25 ROCE 6.8% · OPM 65.1% 57% evidence | 9.6/20 P/E 49× · PEG — 15% evidence | 7.4/20 RS sector -20.3% · RS bench 1% · 1Y -12.1%6 of 12 weeks ahead to 2025-09-24 70% evidence | |
| Exact sum: 19 + 11.8 + 9.6 + 7.4 = 47.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Bharat Global Developers LtdBGDL | 46.9/100Thin evidence · provisional47% evidence | 15.6/35 Revenue -74% · PAT -80% · OPM change 4.2 pp 53% evidence | 10.8/25 ROCE 11.3% · OPM — 46% evidence | 8.5/20 P/E 291× · PEG — 15% evidence | 12.0/20 RS sector 165.8% · RS bench -70.1% · 1Y -17.1%0 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 15.6 + 10.8 + 8.5 + 12 = 46.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Rossell India LtdROSSELLIND | 41.1/100Thin evidence · provisional47% evidence | 14.5/35 Revenue 4.8% · PAT -41.1% · OPM change 0.1 pp 36% evidence | 11.0/25 ROCE 6.4% · OPM 10.7% 71% evidence | 10.8/20 P/E 11.8× · PEG — 15% evidence | 4.8/20 RS sector -28.8% · RS bench -19.6% · 1Y -35%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 14.5 + 11 + 10.8 + 4.8 = 41.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Kesar Enterprises LtdKESAR | 33.6/100Thin evidence · provisional42% evidence | 14.2/35 Revenue -55.3% · PAT -80% · OPM change 7.4 pp 40% evidence | 5.9/25 ROCE -26.2% · OPM 2.8% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.5/20 RS sector -44.4% · RS bench -39.4% · 1Y -66.4%0 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 14.2 + 5.9 + 10 + 3.5 = 33.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Nurture Well Industries Ltd's share price today?
Nurture Well Industries Ltd trades at ₹24.8, +24.6% over the past year. The company is valued at ₹576 Cr. The stock sits at 25% of its 52-week range of ₹18–₹44, −16.7% versus its 200-day average. On the tape, the price is in a downtrend, 9 weeks in. — as of 31 July 2026.
What were Nurture Well Industries Ltd's latest quarterly results?
Nurture Well Industries Ltd reported revenue of ₹200 Cr and a net loss of ₹1.2 Cr for the Mar 26 quarter. Revenue fell 16.8% and profit fell 105.2% year on year. Earnings per share were ₹−0.04. The operating margin was 0.2%, 9.1 pp lower than a year earlier. — as of 31 July 2026.
What is Nurture Well Industries Ltd's revenue?
Nurture Well Industries Ltd reported revenue of ₹200 Cr in the Mar 26 quarter, −16.8% year on year. For the full FY26 fiscal year, revenue was ₹1,026 Cr (+33.9%). — as of 31 July 2026.
What is Nurture Well Industries Ltd's profit?
Nurture Well Industries Ltd earned ₹−1.2 Cr of net profit in the Mar 26 quarter, −105.2% year on year. Full-year FY26 profit was ₹85.0 Cr. The operating margin ran 0.2% in the latest quarter. — as of 31 July 2026.
What is Nurture Well Industries Ltd's market cap?
Nurture Well Industries Ltd's market capitalisation is ₹576 Cr at a share price of ₹24.8. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Nurture Well Industries Ltd's P/E ratio?
Nurture Well Industries Ltd trades at a P/E of 8.6×, at the 14th percentile of its own 3-year range, against a long-run median of 11.5×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Nurture Well Industries Ltd pay a dividend?
No — Nurture Well Industries Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.
Is Nurture Well Industries Ltd overvalued?
On its own history, Nurture Well Industries Ltd looks cheap against its own history: its P/E of 8.6× has been cheaper only 14% of the time in 3 years (long-run median 11.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Nurture Well Industries Ltd growing?
Not right now — Nurture Well Industries Ltd's latest numbers are shrinking: latest-quarter revenue −16.8% year on year, profit −105.2%, and the margin −9.1 pp at 0.2%. The earnings engine currently reads: deteriorating — as of 31 July 2026.
How is Nurture Well Industries Ltd performing?
Nurture Well Industries Ltd is in a downtrend, 9 weeks in. Its latest quarter's revenue fell 16.8% and profit fell 105.2% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 16 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Nurture Well Industries Ltd in?
Mixed — no clean majority across the growth curves, ROCE slipping at 23.0% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +34.0% latest, profit growth −105.2% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Nurture Well Industries Ltd in an uptrend?
No — the price is in a downtrend (week 9 of stage 4), trading −16.7% versus its 200-day average and at 25% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Nurture Well Industries Ltd beating the market?
Not lately — on a trailing-13-week view Nurture Well Industries Ltd is currently behind the NIFTY 500 (16 weeks and counting; last ahead the week of 2026-04-30), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +27,400% against the NIFTY 500's +264% — ahead of the index over the full window. — as of 31 July 2026.
Will Nurture Well Industries Ltd's share price go up?
This page publishes no price forecast for Nurture Well Industries Ltd. What it measures instead: the share price is ₹24.8, the price is in a downtrend 9 weeks in. Its P/E of 8.6× sits at the 14th percentile of its own 3-year range. — as of 31 July 2026.
Who owns Nurture Well Industries Ltd?
Promoters hold 53.8% of Nurture Well Industries Ltd, foreign institutions 0.1%, domestic institutions 0.2% and the public 46.0% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 5.8 points over 8 quarters. — as of 31 July 2026.
Does Nurture Well Industries Ltd have too much debt?
No — Nurture Well Industries Ltd's debt-to-equity is 0.09, and operating profit covers the interest bill 90×. FY26 borrowings were ₹35.0 Cr against equity of ₹370 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.
What is Nurture Well Industries Ltd's capex?
Nurture Well Industries Ltd spent ₹112 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹34.0 Cr, with ₹4.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Nurture Well Industries Ltd's cash flow?
Nurture Well Industries Ltd generated ₹−22.0 Cr of operating cash flow in FY26 and ₹−56.0 Cr of free cash flow after ₹34.0 Cr of capital spending. Reported profit that year was ₹85.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Nurture Well Industries Ltd's profit real cash?
Not fully — over the last 3 fiscal years, −8% of Nurture Well Industries Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹−22.0 Cr against reported profit of ₹85.0 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 31 July 2026.
Where is Nurture Well Industries Ltd in its business cycle?
Nurture Well Industries Ltd's FY26 operating margin was 9.0%, against a 6-year band of −33.3%–1,788.2%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 0.2%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Nurture Well Industries Ltd story?
The sharpest disagreement: the P/E sits at the 14th percentile of its own range, but the engine is deteriorating — cheap for a reason until the quarters turn. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Nurture Well Industries Ltd a stock worth studying right now?
This is not investment advice. The machine read: Nurture Well Industries Ltd is cheap for a reason. The P/E sits at the 14th percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the quarters turn before the discount closes. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.